A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61K 38/19 (2006.01) A61K 39/395 (2006.01) A61K 48/00 (2006.01) A61P 7/06 (2006.01) A61P 9/00 (2006.01) A61P 13/12 (2006.01)
Patent
CA 2340320
The invention concerns the prevention and treatment of endothelial injury and the injury of tissues containing injured blood vessels by administration of angiogenic factors, such as vascular endothelial cell growth factor (VEGF).
L'invention concerne la prévention et le traitement de lésions endothéliales et de lésions de tissus contenant des vaisseaux sanguins atteints, cette prévention et ce traitement consistant à administrer des facteurs angiogéniques, tels que le facteur de croissance cellulaire endothélial vasculaire.
Johnson Richard J.
Schreiner George F.
Scios Inc.
Sim & Mcburney
University Of Washington
LandOfFree
Use of an angiogenic factor for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of an angiogenic factor for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of an angiogenic factor for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1776994